Healthcare -
Biotechnology - NASDAQ - US
$ 44.405
-3.47 %
$ 5.26 B
Market Cap
-8.44
P/E
CYTK - LONG-TERM DEBT
Long-term Debt CYTK - Cytokinetics, Incorporated
728 M
LAST VALUE
68.92%
2 YEAR CAGR
78.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR